Finance

Lists
EII:FRA
Eisai Co Ltd
€25.73
-2.32%
(-0.61) 1D
Sep 11, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EII...
Open
€25.73
High
€25.73
Low
€25.73
Mkt. cap
9.19B
Avg. vol.
10.00
Volume
0.00
52-wk high
€30.25
52-wk low
€19.70
No. of employees
11K
Open
€25.73
High
€25.73
Low
€25.73
Mkt. cap
9.19B
Avg. vol.
10.00
Volume
0.00
52-wk high
€30.25
52-wk low
€19.70
No. of employees
11K
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees10.5K
FoundedDec 6, 1941
HeadquartersBunkyo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteeisai.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
197.36B
219.94B
205.43B
234.33B
Cost of goods sold
45.52B
51.08B
52.02B
51.09B
Cost of revenue
45.52B
51.08B
52.02B
51.09B
Research and development expenses
36.74B
39.20B
43.94B
43.71B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104.06B
111.72B
108.23B
114.83B
Operating expense
138.36B
148.82B
163.92B
158.51B
Total operating expenses
183.88B
199.90B
215.94B
209.60B
Operating income
13.48B
20.03B
-10.51B
24.73B
Other non operating income
1.00M
-1.00M
-66.00M
-2.00M
EBT including unusual items
14.53B
22.00B
-7.94B
25.28B
EBT excluding unusual items
14.34B
22.00B
-10.55B
25.28B
Income tax expense
4.00B
4.16B
-4.75B
6.13B
Effective tax rate
27.51%
18.90%
59.77%
24.25%
Other operating expenses
-2.44B
-2.10B
250.00M
-28.00M
Net income
10.16B
17.18B
-3.25B
18.24B
Net profit margin
5.15%
7.81%
-1.58%
7.78%
Earnings per share
-
-
-
-
Interest and investment income
2.30B
3.40B
462.00M
2.51B
Interest expense
-1.44B
-1.43B
-439.00M
-1.96B
Net interest expenses
856.00M
1.97B
23.00M
556.00M
Depreciation and amortization charges
-
-
11.51B
-
EBITDA
23.29B
30.10B
-530.00M
34.15B
Gain or loss from assets sale
1.31B
-
1.40B
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps